Overview

Prophylactic Use of Filgrastim SD/01 in Patients With Hodgkin's Disease Receiving ABVD Chemotherapy

Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
Prophylactic use of Filgrastim SD/01 for patients with Hodgkin's lymphoma receiving ABVD chemotherapy.
Phase:
Phase 3
Details
Lead Sponsor:
M.D. Anderson Cancer Center
Treatments:
Bleomycin
Dacarbazine
Doxorubicin
Lenograstim
Liposomal doxorubicin
Vinblastine